Detalles de la búsqueda
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med
; 390(15): 1394-1407, 2024 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587233
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622681
3.
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
Circulation
; 149(19): 1474-1489, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533643
4.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Circulation
; 149(3): 204-216, 2024 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952180
5.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599221
6.
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739118
7.
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
Circulation
; 148(10): 834-844, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534453
8.
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies.
Annu Rev Med
; 73: 321-337, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379445
9.
Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial.
J Card Fail
; 2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38211934
10.
Feasibility of Noninvasive Assessment of Cardiac Output during Exercise in Healthy Adults by a Novel Elaboration on Systolic Time Intervals.
Cardiology
; 149(2): 183-188, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827127
11.
Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications.
Eur Heart J
; 44(48): 5049-5060, 2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639219
12.
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
Eur Heart J
; 44(22): 1979-1991, 2023 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36879444
13.
Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
Circulation
; 146(4): 339-357, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877831
14.
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
Circulation
; 145(21): 1592-1604, 2022 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354306
15.
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Lancet
; 399(10330): 1130-1140, 2022 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120593
16.
Decoupling of Hemodynamics and Congestive Symptoms in Obese Patients With Heart Failure.
J Card Fail
; 29(9): 1249-1256, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963608
17.
Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study.
J Card Fail
; 29(4): 463-472, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36243338
18.
Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction.
Circ J
; 87(8): 1039-1046, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645733
19.
Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.
Eur Heart J
; 43(20): 1941-1951, 2022 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139159
20.
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Eur Heart J
; 43(36): 3417-3431, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796488